Filter by

Topics

PCR TOKYO VALVES 2023 Abstract Book

FIND IN THIS CATALOGUE ALL THE PCR TOKYO VALVES 2023 SELECTED ABSTRACTS AND E-POSTERS.

FILTER BY TOPIC OR USE THE FREE SEARCH.

YOU CAN RATE, COMMENT OR CONTACT EACH AUTHOR.

A36610AL
A long-term longitudinal 3D echo study of mitral valve remodeling after myocardial infarction: implication for transcatheter mitral valve repair for evolving functional mitral regurgitation
ALEX L. (1), LEE C. W. (1), LAM Y. Y. (2), FAN Y. (3), SATISH S. (4), EWE S. H. (5), HONG G. R. (6), SUNG S. H. (7), LEE C. W. (7)
(1) The Chinese University of Hong Kong (CUHK), Ma Liu Shui HONG KONG
(2) Hong Kong Asia Heart Centre, Admiralty HONG KONG
(3) Shanghai Chest Hospital, Shanghai CHINA
(4) Apollo Hospitals, Greams Lane, Off Greams Road, Chennai INDIA
(5) National Heart Centre Singapore, National Heart Centre Singapore SINGAPORE
(6) Severance Hospital, Seoul REPUBLIC OF KOREA
(7) Taipei Veterans General Hospital台北榮民總醫院, Taipei City TAIWAN
A36921HK
Objective quantification of post-TAVI aortic regurgitation in real-world using 12 different types of transcatheter heart valves: a multicentre pooled analysis
KAWASHIMA H. (1), ELKOUMY A. (2), ABDELSHAFY M. (2), ELZOMOR H. (2), WANG R. (3), TAO L. (3), ONUMA Y. (2), SERRUYS P. (2), SOLIMAN O. (2)
(1) Teikyo University Hospital, Tokyo JAPAN
(2) National University of Ireland, Galway, Galway IRELAND
(3) Xijing Hospitals, 内 CHINA
A37285RG
Clinical outcomes with Portico transcatheter heart valves: an Australian single-centre experience
PRENDERGAST S. (1), GRAY R. (1), SAMUEL P. (1), LIM Z. Z. (1), SARATHY K. (1), KUSHWAHA V. (1), JEPSON N. (1)
(1) Prince Of Wales Hospital, NSW AUSTRALIA
A37315RC
Characteristics and clinical outcomes of atrial fibrillation patients undergoing both catheter ablation and left atrial appendage occlusion
CHATANI R. (1), TASAKA H. (1), ISHIMURA R. (1), MUSHIAKE K. (1), ONO S. (1), OHYA M. (1), KUBO S. (1), MARUO T. (1), KADOTA K. (1)
(1) Kurashiki Central Hospital, Okayama JAPAN
A37317HY
Outcomes of COMBO therapy for severe mitral regurgitation compared with transcatheter edge-to-edge repair
YOKOYAMA H. (1), BARDELEBEN R. S. (2), SAITO S. (1)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) Mainz University, Mainz GERMANY
A37318PV
Efficacy of cerebral protection during TAVI: a systematic review and meta-analysis
VRIESENDORP P. (1), KATS S. (1), LEO V. (1), LUX A. (1), MAESEN B. (1), VAN 'T HOF A. (1)
(1) Mumc+, Maastricht NETHERLANDS
A37346AM
Prognostic value of paradoxical low-flow low-gradient severe aortic stenosis in patients undergoing TAVI
MASUMOTO A. (1), TAKAHASHI N. (1), TSUNAMOTO H. (1), TSUKIYAMA Y. (1), ONISHI T. (1), TAKAYA T. (1), KAWAI H. (1), SAKAMOTO T. (1), NOMURA Y. (1), MURAKAMI H. (1)
(1) Harima-Himeji General Medical Center, Himeji JAPAN
A37349PO
Deep learning-based prediction of early cerebrovascular events after TAVR
OVERTCHOUK P. (1), OKUNO T. (1), ASAMI M. (1), TOMII D. (1), STEFAN S. (1), PRAZ F. (1), LANZ J. (1), SIONTIS G. (1), GRäNI C. (1), WINDECKER S. (1), PILGRIM T. (1)
(1) Inselspital, Bern SWITZERLAND
A37396MF
Deformation of transcatheter heart valve after aortic valve-in-valve: implications for haemodynamics
FUKUI M. (1), SORAJJA P. (1), ENRIQUEZ-SARANO M. (1), SATO H. (1), OKADA A. (1), LESSER J. (1), CAVALCANTE J. (1), BAPAT V. (1)
(1) Minneapolis Heart Institute Foundation, MN UNITED STATES
A37411JA
Contemporary three-year outcomes from 500 patients treated with MitraClip : results from the Japan post-marketing Surveillance study
IZUMO M. (1)
(1) St. Marianna University School of Medicine, Kanagawa JAPAN
A37412JM
Challenging cases with extra-support double wire in TAVR for severely calcified and tortuous cardiovascular vessels by the femoral access
MIERES J. (1), FERNANDEZ-PEREIRA C. (1), AZCARRUNS D. (1), RODRIGUEZ-GRANILLO M. (1), PAVLOVSKY H. (1), CARVAJAL F. (1), RODRIGUEZ A. E. (1)
(1) Otamendi y Miroli, Buenos Aires ARGENTINA
A37427QW
The Malaysian MitraClip registry – 12 years experience of transcatheter edge-to-edge repair in a multi-ethnic population
WY JIN Q. (1), GHAZI A. (1), YOUSIF HAROON A. (1), ARIFF NURUDDIN A. (1)
(1) Institut Jantung Negara, Federal Territory of Kuala Lumpur MALAYSIA
A37431KS
Short-term outcomes of TAVI by using balloon-expandable valve in dialysis patients
SHISHIDO K. (1), YAMANAKA F. (1), MORIYAMA N. (1), OCHIAI T. (1), MIYASHITA H. (1), YOKOYAMA H. (1), SAITO S. (1)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
A37435HL
Change of renal function and long-term outcomes in aortic stenosis patients with chronic kidney disease undergoing TAVR
LIN H. C. (1), YIN W. H. (1), LEE K. C. (1), TSAO T. P. (1), LEE K. C. (1), WEI J. (1)
(1) Cheng Hsin General Hospital, Taipei City TAIWAN
A37436HM
Ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVI
MIYASHITA H. (1), MORIYAMA N. (1), DAHLBACKA S. (2), VäHäSILTA T. (2), VAINIKKA T. (2), JALANKO M. (2), VIIKILä J. (2), LAINE M. (2)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) HUS, Helsinki FINLAND
A37437HM
Predictors of conduction disturbances after TAVI with balloon-expandable valve for bicuspid aortic valve stenosis
MIYASHITA H. (1), MORIYAMA N. (1), YAMANAKA F. (1), SAITO S. (1), LEHTOLA H. (2), PIUHOLA J. (2), NIEMELä M. (2), LAINE M. (3)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) Oulun yliopistollinen sairaala, Oulu FINLAND
(3) HUS, Helsinki FINLAND
A37438HM
Early haemodynamic outcomes in self-expandable valves: comparison of ACURATE Neo vs. ACURATE Neo2
MIYASHITA H. (1), MORIYAMA N. (1), LAINE M. (2)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) HUS, Helsinki FINLAND
A37441HM
Early clinical and haemodynamic outcomes in TAVR with NAVITOR valve
MIYASHITA H. (1), YOKOYAMA H. (1), OCHIAI T. (1), MORIYAMA N. (1), SHISHIDO K. (1), YAMANAKA F. (1), SAITO S. (1)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
A37442NM
Long-term assessment of survival after TAVR
MORIYAMA N. (1), SUGIYAMA Y. (2), MIYASHITA H. (1), JALANKO M. (2), YAMANAKA F. (1), VAHASILTA T. (2), SAITO S. (1), LAINE M. (2)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) University of Helsinki, Helsinki FINLAND
A37443HM
Clinical outcomes and economic impact of next-day-discharge following TAVR
MIYASHITA H. (1), MORIYAMA N. (1), LAINE M. (2)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) HUS, Helsinki FINLAND
A37447HM
Conduction disturbance after TAVR with self- or balloon-expandable valve according to the implantation depth
MIYASHITA H. (1), MORIYAMA N. (1), LAINE M. (2)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
(2) HUS, Helsinki FINLAND
A37451HS
Complications of rotational atherectomy in patients with severe aortic stenosis: a systematic review of observational studies
SRITHARAN H. (1), BHATIA K. (2), ALLAHWALA U. (1), WARD M. (1), BANNING A. (3), BHINDI R. (1)
(1) Royal North Shore Hospital, NSW AUSTRALIA
(2) Bankstown-Lidcombe Hospital, NSW AUSTRALIA
(3) Oxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford UNITED KINGDOM
A37453TC
The comparison of clinical outcome between experienced and new-built heart team with different prosthesis
CHEN T. W. (1), TSAI Y. L. (1), LEE C. W. (1), HSU C. P. (1), SUNG S. H. (1)
(1) Taipei Veterans General Hospital台北榮民總醫院, Taipei City TAIWAN
A37458AO
Usefulness of preprocedural computed tomography in surgical aortic valve sizing
OKADA A. (1), SATO H. (1), KOIKE H. (1), FUKUI M. (1), HAMID N. (1), ENRIQUEZ-SARANO M. (1), LESSER J. (1), SUN B. (1), CAVALCANTE J. (1), SORAJJA P. (1), BAPAT V. (1)
(1) Minneapolis Heart Institute Foundation, MN UNITED STATES
A37459KO
A feasibility of simultaneous procedure of MitraClip and Watchman implantation
OSAKADA K. (1), KUBO S. (1), NISHIURA N. (1), MUSHIAKE K. (1), CHATANI R. (1), ONO S. (1), OHYA M. (1), MARUO T. (1), KADOTA K. (1)
(1) Kurashiki Central Hospital, Okayama JAPAN
A37460HS
The impact of device-lead extraction in severe tricuspid regurgitation
SATO H. (1), ENRIQUEZ-SARANO M. (1), BAPAT V. (1), CAVALCANTE J. (1), BAE R. (1), HAMID N. (1), FUKUI M. (1), OKADA A. (1), ZAKAIB J. (1), GORNICK C. (1), SORAJJA P. (1)
(1) Minneapolis Heart Institute Foundation, MN UNITED STATES
A37470FO
Direct oral anticoagulants or vitamin K antagonists after TAVR: a systematic review and meta-analysis
OLIVERI F. (1), MONTALTO C. (2), TUA L. (1), LANZILLO G. (1), COMPAGNONI S. (1), FASOLINO A. (1), GENTILE F. R. (1), FERLINI M. (3), PEPE A. (1), BONGIORNO A. (1), LEONARDI S. (1)
(1) The University of Pavia, Province of Pavia ITALY
(2) Ospedale Niguarda, Metropolitan City of Milan ITALY
(3) Fondazione I.R.C.C.S. Policlinico San Matteo, Province of Pavia ITALY
A37472CL
Leaflets or annulus restoration after transcatheter edge-to-edge mitral valve repair in patients with secondary mitral regurgitation
LEE C. W. (1), TSAI Y. L. (1), CHANG C. C. (1), CHEN S. Z. (1), SUNG S. H. (1)
(1) Taipei Veterans General Hospital台北榮民總醫院, Taipei City TAIWAN
A37488MV
Dosage affects bleeding outcomes in edoxaban patients with creatinine clearance levels near the dose-adjustment threshold: a subanalysis of the ENVISAGE-TAVI AF trial
MEHRAN R. (1), VAN MIEGHEM N. (2), UNVERDORBEN M. (3), HENGSTENBERG C. (4), VRANCKX P. (5), MORENO R. (6), VALGIMIGLI M. (7), JIN J. (3), VELTKAMP R. (8), DANGAS G. (1)
(1) Mount Sinai Medical Center, NY UNITED STATES
(2) Erasmus MC, Rotterdam NETHERLANDS
(3) Daiichi Sankyo, Inc., NJ UNITED STATES
(4) Medical University of Vienna, Vienna AUSTRIA
(5) Jessa Hospital, Hasselt BELGIUM
(6) Hospital Universitario La Paz, Madrid SPAIN
(7) University of Italian Switzerland, Lugano SWITZERLAND
(8) Imperial College London, London UNITED KINGDOM
A37500HK
Transcatheter mitral valve-in-valve procedure using balloon-expandable transcatheter heart valve in prohibitive or high surgical risk patients with bioprosthetic valve failure in Korea
KOOK H. (1), YU C. W. (2), LIM Y. H. (1), KIM W. (1)
(1) Hanyang University Hospital, Seoul REPUBLIC OF KOREA
(2) Korea University Anam Hospital, Seoul REPUBLIC OF KOREA
A37553SU
Utilisation of STAT Seal in large bore femoral vascular access in TAVI
UPADHYAYA S. (1), KHOGALI S. (1)
(1) New Cross Hospital, Wolverhampton UNITED KINGDOM
A37667YC
Transcatheter valve replacement with a novel tricuspid bioprosthesis in experimental models
QUADRI A. (1), CHENG Y. (2), YI G. (2), ORDANES D. (2), SONDERGAARD L. (3), KAR S. (4)
(1) inQB8 Medical Technologies, LLC. , Winchester UNITED STATES
(2) Cardiovascular Research Foundation, NY UNITED STATES
(3) Copenhagen University Hospital, Rigshospitalet, Copenhagen Municipality DENMARK
(4) Los Robles Regional Medical Center, CA UNITED STATES
A37672HS
Efficacy and feasibility of PCI with chimney-stenting technique during self-expanding TAVI
SUZUYAMA H. (1), KONAMI Y. (1), HORIO E. (1), EIJI T. (1), SASSA T. (1), IDETA I. (1), HORIBATA Y. (1), YAMADA M. (1), MAEDA M. (1), SAKAMOTO T. (1)
(1) Saiseikai Kumamoto Hospital, Kumamoto JAPAN
A37682GS
Cerebral embolic protection devices for stroke prevention during TAVI: an updated meta-analysis
SAYAT G. (1), GONZALES-PORCIUNCULA L. A. (1), VILLANGCA S. (1), GERODIAS F. J. (1)
(1) St. Luke?s Medical Center, Metro Manila PHILIPPINES
A37684ML
Symptomatology of mitral valve diseased patients who are waiting to undergo surgery
LANSAKARA M. (1), LANSAKARA M. (1), KUMARI V. (1)
(1) National Hospital - Kandy, Kandy SRI LANKA
A37687FL
TricValve implantation in Asian patients
LIM F. Y. (1), WONG N. (1), JAPPAR I. (1), EWE S. H. (1), TAN J. W. C. (1), YEO K. K. (1)
(1) National Heart Centre Singapore, National Heart Centre Singapore SINGAPORE
A37691FL
Use of single TriClip G4 guide for mitral and tricuspid transcatheter edge-to-edge repair
LIM F. Y. (1), WONG N. (1), JAPPAR I. (1), TAN J. W. C. (1), YEO K. K. (1), EWE S. H. (1)
(1) National Heart Centre Singapore, National Heart Centre Singapore SINGAPORE
A37692SG
Benefits of a nurse practitioner model to a TAVI service
GRES S. (1)
(1) Heart HQ Sippy Downs, QLD AUSTRALIA
A37693SG
We present our experience of managing the rapid evolution of our TAVI programme in a regional non-metropolitan private hospital setting
GRES S. (1)
(1) Heart HQ Sippy Downs, QLD AUSTRALIA
A37699GF
Valve thrombosis after TAVR or open surgery aortic bioprosthesis: short and long-term therapeutical strategies
FRIEDRICH G. (1), FEUCHTNER G. (1), MüLLER S. (1), PLANK F. (1), BONAROS N. (1)
(1) Universität Innsbruck, Innsbruck AUSTRIA
A37702SG
Challenges of successful TAVI programme in non metropolitan private hospital setting
GRES S. (1)
(1) Heart HQ Sippy Downs, QLD AUSTRALIA
A37707TO
Impact of high implantation of transcatheter aortic valve on subsequent conduction disturbances and coronary access
OCHIAI T. (1), YAMANAKA F. (1), SHISHIDO K. (1), MORIYAMA N. (1), SAITO S. (1)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN
A37708EK
Association of aortic valvular complex calcification burden with procedural and long-term clinical outcomes after TAVR
KO E. (1), KANG D. Y. (2), AHN J. M. (2), PARK S. J. (2), PARK S. J. (2)
(1) Kokura Memorial Hospital, Fukuoka JAPAN
(2) Asan Medical Center, Seoul REPUBLIC OF KOREA
A37763RI
Impact of transition from WATCHMAN to WATCHMAN FLX for percutaneous LAA occlusion
ISHIMURA R. (1), KUBO S. (1), MUSHIAKE K. (1), CHATANI R. (1), ONO S. (1), OSAKADA K. (1), OHYA M. (1), TASAKA H. (1), MARUO T. (1), KADOTA K. (1)
(1) Kurashiki Central Hospital, Okayama JAPAN
A37771HH
Impact of pre-dilatation on bioprosthetic valve dysfunction after TAVI
HIOKI H. (1), WATANABE Y. (1), KAWASHIMA H. (1), KITO K. (1), KATAYAMA T. (1), KATAOKA A. (1), YOKOYAMA N. (1), KOZUMA K. (1)
(1) Teikyo University Hospital, Tokyo JAPAN
A37791MS
Efficacy of TAVR for intradialytic hypotension in patients with severe aortic stenosis
SAIGAN M. (1), MIYASAKA M. (1), HIROSE S. (1), NAKASHIMA M. (1), ISHII K. (1), ENTA Y. (1), TOKI Y. (1), MUNEHISA Y. (1), TADA N. (1)
(1) Sendai Kousei Hospital, Miyagi JAPAN
A37800KN
Clinical and angiographic profile of young ACS patients in Shahid Gangalal National Heart Centre, Kathmandu, Nepal
NEUPANE K. (1), NEUPANE K. (1), SIMKHADA R. (1)
(1) Shahid Gangalal National Heart Center, Kathmandu NEPAL
A37810TF
The usefulness of Micra AV for complete atrioventricular block after TAVR
FUKUSHIMA T. (1), TSURU Y. (1), TASHIRO H. (1), MOROFUJI T. (1), TABATA H. (1), ISHIZU K. (1), HAYASHI M. (1), ISOTANI A. (1), SHIRAI A. (1), ANDOU K. (1)
(1) Kokura Memorial Hospital, Fukuoka JAPAN
A37825MS
Prognostic factors in patients undergoing percutaneous mitral valve repair for functional mitral regurgitation in patients with reduced left ventricular ejection fraction
SONE M. (1), KIKUCHI N. (1), ARASHI H. (1), YOSHIKAWA M. (1), MINAMI Y. (1), SAITO C. (1), SUAUKI A. (1), DOMOTO S. (2), NIINAMI H. (2), YAMAGUCHI J. (1)
(1) Department of Cardiology, Tokyo Women's Medical University, Tokyo JAPAN
(2) Department of Cardiovascular surgery, Tokyo Women's Medical University, Tokyo JAPAN
A37829AK
Coronary access after TAV-in-TAV procedure in patients with a small body size: a single-centre simulation study
KAWAMURA A. (1), MAEDA K. (1), SHIMAMURA K. (1), YAMASHITA K. (1), MATSUHIRO Y. (1), MUKAI T. (1), NAKAMURA D. (1), MIZOTE I. (1), SAKATA Y. (1), MIYAGAWA S. (1)
(1) Osaka University Graduate School of Medicine, Suita JAPAN
Loading...